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Concern has been expressed in recent years
over the apparent worsening of male repro-
ductive health, after reports of increasing fre-
quency of testicular cancer (Forman and
Moller 1994; Toledano et al. 2001) and of
congenital malformations of the male urogeni-
tal organ, such as hypospadias (Kallen et al.
1986; Paulozzi et al. 1997). There are also
suggestions that sperm quality may be decreas-
ing in both Europe and the United States,
although it is unclear whether this decrease is
real or artifactual (Giwercman et al. 1993;
Swan et al. 1997). A hypothesis that increas-
ing exposure to environmental endocrine-dis-
rupting agents, such as estrogenic compounds,
may be responsible for these trends has been
proposed (Sharpe and Skakkebaek 1993) but
remains controversial (Cooper and Kavlock
1997; Harrison 2001; Joffe 2001).
Supporting evidence (primarily from
Great Britain) for adverse male reproductive
effects comes from the rising incidence of
cryptorchidism, defined as the absence of at
least one testis in the scrotum (Cortes 1998),
and of orchidopexy, the operation carried out
to correct the anomaly. Findings from a large
cohort study in Oxford revealed a 93%
increase in cryptorchidism rates between the
1950s and late 1980s (John Radcliffe
Hospital Cryptorchidism Study Group
1992), whereas in England and Wales, the
hospital discharge rate for orchidopexy
increased from 1.4% for boys born in 1952
to 2.9% for those born in 1977 (Chilvers et
al. 1984). Larger increases in both cryp-
torchidism and orchidopexy rates were
reported from Scotland for the early 1970s to
1985 (Campbell and Webb 1987).
Although it is often assumed that cryp-
torchidism (and thus orchidopexy) rates have
continued to increase, few recent data on
trends have been reported. This study aimed to
update the descriptive epidemiology of cryp-
torchidism in Great Britain over the period
1992–1998. It forms part of a wider investiga-
tion into the temporal and spatial trends of tes-
ticular cancer in Great Britain (Toledano et al.
2001), because cryptorchidism is a well-estab-
lished risk factor for this cancer (Depue et al.
1986; Moller et al. 1995).
Methods
Hospital episodes (deﬁned as a “ﬁnished con-
sultant episode”) for orchidopexy procedures
[Office of Population Censuses and Surveys
(OPCS)-4 codes N08 and N09] (OPCS
1990) were extracted from routine hospital
admission data for England [Hospital
Episode Statistics (HES)], Wales (Patient
Episode Data Wales), and Scotland (Scottish
Hospital In-Patient Statistics) for the fiscal
years 1992–1993 through 1998–1999.
Readmissions, detected by matching on date
of birth and postcode, were removed.
Episodes for those of indeterminate sex were
excluded. Where an episode included more
than one orchidopexy procedure, it was
counted only once.
We analyzed annual trends by age (0–4,
5–9, 10–14, and ≥ 15 years old), whether in-
patient admission or day case, and by country
or health region in England (1996 bound-
aries), using male annual population esti-
mates from the Ofﬁce for National Statistics
as the denominator for rates.
Because increasing use of day-case proce-
dures for orchidopexy may have led to
incomplete capture of hospital admissions
data, the General Practice Research Database
(GPRD) was also examined. This is the
largest national computerized source of rou-
tine information on general practice morbid-
ity and prescribing, covering 5.6% of the
population of England and Wales in 1994
(Office for National Statistics 1996).
Information on orchidopexy in the GPRD
comes from hospital discharge letters sent to
general practitioners, covering both day-case
and in-patient procedures. The first ever
mention of orchidopexy by age in years and
the total male person-years at risk (pyar) for
the calendar years 1992–1996 were identiﬁed
for general practitioner practices that had par-
ticipated in the GPRD throughout this time
period. Analysis was restricted to practices in
England. To determine the indication for
orchidopexy, 50 randomly selected and
anonymized patient records from 1992 and
Address correspondence to P. Elliott, Department of
Epidemiology and Public Health, Faculty of
Medicine, Imperial College, St Mary’s Campus,
Norfolk Place, London W2 1PG UK. Telephone:
44-20-7594-3328. Fax: 44-20-7402-2150. E-mail:
p.elliott@ic.ac.uk
We thank D. Wilcox (Consultant Paediatric
Urologist, Great Ormond Street Hospital, London)
and P. Steer (Professor of Obstetrics and
Gynaecology, Chelsea and Westminster Hospital,
London) for their helpful comments. We thank the
(English) Department of Health, Welsh National
Assembly, and General Register Office for Scotland
for the provision of and permission to use the data. 
The Small Area Health Statistics Unit is funded by
a grant from the Department of Health; Department
of the Environment, Food and Rural Affairs;
Environment Agency; Health and Safety Executive;
Scottish Executive; National Assembly for Wales;
and Northern Ireland Assembly. 
The views expressed in this publication are those
of the authors and not necessarily those of the fund-
ing departments, data providers, or the Office for
National Statistics.
Received 11 January 2002; accepted 5 August 2002.
Concern has been expressed in recent years about worsening male reproductive health, possibly
mediated by increasing exposures to environmental endocrine-disrupting agents. Trends suggested
large increases in cryptorchidism in Britain and the United States between the 1950s and 1980s,
although published data on recent trends have been scarce. We examined numbers of orchidopexy
procedures, as a marker for cryptorchidism, using routine hospital admission data for England,
Wales, and Scotland for fiscal years 1992–1993 through 1998–1999. Annual trends in orchi-
dopexy rates were analyzed by age, in-patient admission versus day case, and geographical region.
Orchidopexy rates were also obtained from the General Practice Research Database (GPRD) for
England to cross-validate the hospital admissions data. Orchidopexy rates for boys 0–14 years old
fell by 33% (from 23.5 to 15.8 per 10,000 population) between 1992 and 1998, with the steepest
decline (50%) in 5–9-year-olds. The decreasing trend for 0–14-year-olds was evident in every
region in England, in Wales, and in Scotland. Rates remained stable for men 15 or more years old,
at 0.7 per 10,000. There was a marked shift from in-patient to day-case procedures. Rates from
the GPRD showed a similar downward trend to the hospital data. Our ﬁndings could represent
either an underlying decrease in the frequency of undescended testis or a fairly dramatic improve-
ment in the diagnosis of cryptorchidism—resulting in fewer orchidopexies performed for retractile
testis—in Great Britain during the 1990s, or both. Either way, our ﬁndings do not support the
postulate of a recent worsening of male reproductive health of the scale suggested by some recent
commentators on the endocrine disruptor hypothesis. Key words: cryptorchidism, endocrine,
orchidopexy, routine health data, temporal trends, testes. Environ Health Perspect 111:129–132
(2003). [Online 6 November 2002]
doi:10.1289/ehp.5446 available via http://dx.doi.org/
Children’s Health | Articles50 from 1996 were examined, with approval
of the Scientific Expert Advisory Group for
the GPRD.
Results
Hospital data. In 1992–1993 there were
13,054 orchidopexy episodes for boys 0–14
years old in hospitals in Great Britain; by
1998–1999 there were only 8,762—a 33%
decline over the study period. Corresponding
rates also fell by 33% from 23.5 to 15.8 per
10,000 population. Rates for men ≥ 15 years
old remained stable at 0.7 per 10,000 over
the study period.
Annual trends by age. As shown in Figure
1, the rates of orchidopexy declined in all age
groups in boys < age 15. However, although
there was a 15% decline in the rate for boys
0–4 years old and a 30% decline in those
10–14 years old, the steepest decline (50%,
from 29.1 to 14.4 per 10,000) was seen in boys
5–9 years old. Thus, at the beginning of the
study period, the highest orchidopexy rate was
in boys 5–9 years old, but from 1995 onward
the highest rate was among those 0–4 years old.
Annual trends by region. The decreasing
trend for those 0–14 years old was evident in
every region in England and in Wales and
Scotland (Table 1), although in some regions
rates in 1998–1999 were higher than those in
the preceding year. In 1992–1993, regional
rates for 0–14-year-olds ranged from 16.5 to
34.7 per 10,000, whereas by 1998–1999
regional rates ranged from 13.5 to 18.5 per
10,000 (Table 1). Except in the most recent
year (1998–1999), the highest rates were
found for Scotland, and North Thames had
the lowest rates.
Annual trends by type of admission. As
well as a decline in episodes, a shift from in-
patient to day-case procedures was seen
(Table 2). This pattern was observed in all
regions and across all age groups. Among
those 0–14 years old, there was a 60% decline
in in-patient episodes between 1992 and
1998, with a contemporaneous 18% rise in
the number of day-case episodes. The largest
proportional increase (51%) in day-case
episodes in those < 14 years old was seen
among 0–4-year-olds. By the end of the study
period, some 200 episodes for those ≥ 15
years old were shifted from in-patient to day-
case procedures, resulting in an increase of
(almost) 150% over the small number of day-
case procedures in 1992–1993.
GPRD data. Orchidopexy rates for 0–14-
year-olds in the GPRD fell by 47% from
18.1 per 10,000 pyar in 1992 (relating to 267
patients) to 9.5 per 10,000 pyar in 1996 (163
patients). Results by age showed similar
trends to those seen in the hospital data: The
decline was less steep for 0–4-year-olds than
for 5–9-year-olds, leading to a crossover
between these two age groups in 1994.
Analysis by region showed that each region
experienced a time trend similar to that seen
nationally (not shown).
Examination of anonymized patient
records (all ages) showed that the percentage
of orchidopexies performed for undescended
testis in 1992 was 70% (26 of 37 records
where a diagnosis was listed) and in 1996 was
72% (31 of 43 records with a diagnosis).
Discussion
Recent concerns about possible environmen-
tal influences on trends of cryptorchidism
have highlighted the need for a current
appraisal of its epidemiology. Contrary to
expectations, this study showed an overall 33%
decline in orchidopexy rates in Great Britain in
the 1990s using hospital admissions data, and
a 47% decline in England using GPRD data.
There were declines in all age groups (most
marked in 5–9-year-olds) and in all regions.
Temporal trends in cryptorchidism.
Reported worldwide incidence of undescended
testis varies considerably as a result of differing
study populations and diagnostic criteria
(Toppari and Kaleva 1999), although intro-
duction of a standardized deﬁnition of maldes-
cent (Scorer 1964), reproduced in large cohort
studies (Berkowitz et al. 1993; John Radcliffe
Hospital Cryptorchidism Study Group 1986,
1992), has enabled meaningful comparisons.
In London in the late 1950s, the prevalence of
cryptorchidism was just under 1% at 3 months
(Scorer 1964), but by the late 1980s in an
Oxford study it was 1.8% (John Radcliffe
Hospital Cryptorchidism Study Group 1992).
Information on time trends in cryp-
torchidism can also be obtained from congen-
ital anomaly registers. Although data from the
International Clearinghouse for Birth Defects
Monitoring Systems indicated no general
increase in cryptorchidism rates from 1970 to
the mid-1990s (Paulozzi 1999), U.S. national
rates increased markedly from approximately
20 to 40 per 10,000 total births between
1970 and 1993, and rates in the Canadian
national system increased until about 1980
but thereafter stabilized (Paulozzi 1999).
English data (Paulozzi 1999) showed a sharp
drop in rates around 1990, coinciding with a
change in reporting procedures (OPCS
1995).
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Table 1. Orchidopexy rate per 10,000 (male) population by region and year in Great Britain, 0–14-year-olds, 1992–1993 through 1998–1999.
England
Northern and Anglia and  North  South  South and  West
Year Yorkshire Trent Oxford Thames Thames west Midlands Northwest Wales Scotland
1992–1993 25.1 22.3 24.3 16.5 21.6 24.7 22.2 23.7 22.9 34.7
1993–1994 23.6 23.3 23.4 14.8 19.7 25.0 22.3 24.5 21.4 31.4
1994–1995 22.7 17.3 24.0 14.9 20.2 22.4 22.6 24.7 20.8 28.6
1995–1996 20.0 17.6 24.6 14.8 19.3 19.2 21.0 20.3 18.3 23.3
1996–1997 16.5 16.8 19.1 14.3 16.6 18.0 18.2 19.6 20.4 23.1
1997–1998 13.3 17.6 17.5 11.4 15.1 15.5 15.3 16.3 16.4 21.4
1998–1999 13.9 16.9 18.5 13.5 16.6 15.7 14.5 16.4 15.2 18.1
Table 2. Number (%) of orchidopexy episodes (codes N08 and N09) in Great Britain by type of admission
(% of year’s admissions), year, and age, 1992–1993 through 1998–1999.
0–14-year-olds 15-year-olds and older
Year In-patient Day case In-patient Day case
1992–1993 8,653 (66) 4,401 (34) 1,403 (92) 127 (8)
1993–1994 7,152 (57) 5,423 (43) 1,330 (86) 209 (14) 
1994–1995 5,982 (50) 6,039 (50) 1,202 (83) 245 (17)
1995–1996 5,025 (46) 5,897 (54) 1,261 (82) 281 (18)
1996–1997 4,429 (44) 5,528 (56) 1,320 (80) 320 (20)
1997–1998 3,630 (42) 5,059 (58) 1,129 (78) 327 (22)
1998–1999 3,581 (41) 5,180 (59) 1,172 (79) 314 (21)
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Figure 1. Orchidopexy rate per 10,000 (male) popu-
lation in Great Britain by year and age group,
1992–1993 through 1998–1999.Interpretation of hospital and general
practitioner data on orchidopexy. The use
and interpretation of hospital admission data
are complex. Hospital activity in the United
Kingdom depends not only on the underly-
ing prevalence of disease but also on the diag-
nostic accuracy and referral practice of the
primary care clinician, patient-speciﬁc factors
such as individual preferences, distance of res-
idence from hospital, and socioeconomic class
and on hospital-speciﬁc factors, such as qual-
ity of the hospital data collected, supply of
hospital beds, admission policies, and hospital
access (Hansell et al. 2001). Given such com-
plexities, we investigated whether the
observed decline in orchidopexy rates could
have been artifactual, related to changes in
clinical coding or data-capture problems. 
First, an alternative code to those exam-
ined here could have been used for orchi-
dopexy (“other operations on testis—ﬁxation
of testis,” OPCS-4 code N132) (OPCS
1990). Although the number of episodes
given this code ﬂuctuated annually, there was
an overall decline of 17% over the study
period, and it is unlikely that simple coding
transfer could explain our findings because
the largest annual decline in orchidopexy
episodes was four times greater than the
largest annual decline in the number of oper-
ations given this code. Ideally, our examina-
tion would have included English hospital
admissions data from the 1970s and 1980s
and allowed us to compare time trends in
hospital admissions with those from an indi-
vidual cohort study (John Radcliffe Hospital
Cryptorchidism Study Group 1992).
Unfortunately, hospital admissions data
between 1987 and 1991 are of variable qual-
ity (Aylin et al. 2001), whereas U.K. national
data for the 1970s and 1980s are not readily
available.
Second, increasing use of day-case proce-
dures may have led to incomplete capture of
the frequency of orchidopexy in hospital
episode records. To investigate this possibil-
ity, we used an alternative source of data, the
GPRD, which has proven valuable for exam-
ining rates over time (Kaye et al. 2000). In
validation studies for a range of conditions,
the GPRD has been shown to capture a high
proportion of patient referrals and hospital-
izations (Jick et al. 1991; Kaye et al. 2000).
There seems no obvious reason why these
results should not also apply to orchidopexy.
The GPRD also showed a decline in orchi-
dopexy rates, which was comparable with,
but larger than, that seen in HES, with simi-
lar age-speciﬁc trends.
The recorded rates of orchidopexy in the
GPRD were within the range of those reported
by region in 1992–1993 but declined to
approximately two-thirds the rate of the lowest
region by 1996. There are a number of possi-
ble explanations for the discrepancies in rates
between the two data sources. Although
broadly representative, GPRD practices are
self-selected with underrepresentation in inner
London and of single-handed (one practi-
tioner) practices (Walley and Mangani 1997),
and it should probably not be surprising that
prevalence and/or referral rates differ from
national or regional rates. It is also possible
that, through computerization, these general
practitioners were more readily able to access
records showing that the testes were descended
after birth and thus less likely to misdiagnose
retractile testes as cryptorchidism. Another
explanation is that improvements in diagnosis
occurred faster than that seen nationally. A
ﬁnal possibility is that the HES data used over-
estimate the true prevalence of orchidopexy:
GPRD rates were based on patients, whereas
HES records are based on episodes. Although
we attempted to remove duplicate episodes
and readmissions from the HES records, it is
possible that some were missed.
Changes in surgical practice. By 1995, the
orchidopexy rate was highest for boys 0–4
years old, in contrast to 5–9 years in the ear-
lier period. The trend for earlier age at orchi-
dopexy may be a reﬂection of both academic
(Kass et al. 1996) and, more recently, policy
recommendations (Hall 1996) that cryp-
torchidism be detected and corrected opera-
tively before 2 years of age. In fact, late
orchidopexy rates (orchidopexies done after
the age of 5 years) are used to monitor the
adequacy of child health screening programs,
and regional rates are routinely published
each year (Department of Health 1997). If,
however, such changes in surgical practice
during the early 1990s were the sole cause of
the observed decline in orchidopexy, we
would expect to see an increase in the num-
ber of operations performed in the 0–4-year-
old group, whereas a decrease was observed.
While shifting age trends may reﬂect changes
in surgical practice, they could also be indica-
tive of an underlying birth cohort effect,
although with the limited numbers of years of
data available to us, we were unable to
explore this possibility further.
Over the past two decades, hormone ther-
apy has been proposed in the treatment of
undescended testes, with equivocal reports of
its efficacy (Behrman et al. 2000; Madden
2002). Although the introduction of such
treatment could affect orchidopexy rates, use
in the treatment of cryptorchidism is not
standard practice in the United Kingdom
(Madden 2002) and therefore could not have
greatly influenced the observed declining
trends in orchidopexy reported here.
Use of orchidopexy as a proxy for cryp-
torchidism. The use of orchidopexy rates as a
marker for the prevalence of cryptorchidism
is not straightforward, because interpretation
involves untangling factors that can directly
influence the prevalence of cryptorchidism
from those that influence the relationship
between orchidopexy and cryptorchidism.
Gestational age at delivery will affect
prevalence of cryptorchidism, because physio-
logic descent of the testes takes place in the
third trimester of pregnancy (O’Rahilly and
Muller 2001). In recent years obstetric care,
especially regarding high-risk pregnancies, has
improved, and this may be a factor inﬂuenc-
ing the observed declining trends in orchi-
dopexy—for example, if there were fewer
prematurely born babies during the late 1980s
and 1990s than previously. Information from
a large maternity database in London [St
Mary’s Maternity Information System
(SMMIS); for a general account of the system,
see Chapple (1997)], however, indicated no
systematic change in the incidence of preterm
labor for those babies born at 32 weeks or
later over this time period (Philip Steer.
Personal communication). SMMIS data also
showed a small increase in the number of
babies born with < 32 weeks of gestation,
which, in contrast to the findings presented
here, has the potential to slightly increase the
frequency of undescended testes.
A further issue is the relationship between
orchidopexy and the underlying prevalence of
cryptorchidism. Previous studies have sug-
gested that orchidopexy rates might be dou-
ble (Chilvers et al. 1984) or even several times
(Campbell and Webb 1987; Cooper and
Little 1985; Snick 1984) higher than the
prevalence of cryptorchidism in infancy.
Large differences in these rates increase the
possibility that underlying trends in cryp-
torchidism will be masked.
The differences between orchidopexy and
cryptorchidism rates might partly reﬂect either
misdiagnosed cases of retractile testes (Chilvers
et al. 1984; Cooper and Little 1985; Snick
1984) or the possibility that cryptorchidism is
acquired after birth (Donaldson et al. 1996;
Jackson and John Radcliffe Hospital
Cryptorchidism Research Group 1988), for
which various etiologies have been postulated
(Atwell 1985; Clarnette et al. 1997; Hutson
and Goh 1993; Rabinowitz and Hulbert
1997). The cremaster reﬂex cannot retract the
testes from the scrotum to the superficial
inguinal pouch until about 6 months of age
(Cortes 1998). Peak prevalence of retractile
testes is suggested to be between 5 and 8 years
old (Cortes 1998), and improved diagnosis
might therefore have resulted in a decline in
orchidopexy performed on this age group.
Although this may help explain the patterns in
our data, our analysis of a small sample of gen-
eral practitioner patient records reported here
suggests that around 70% of orchidopexies
were carried out for cryptorchidism, with no
change in this proportion over time.
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in inappropriate surgery for retractile testes
could account for at least some of the declin-
ing trend in orchidopexy.
To illustrate the extent to which orchi-
dopexy rates could provide us with an indica-
tion of the underlying frequency of
cryptorchidism—given the complexities in
the relationship between orchidopexy and
cryptorchidism outlined above—a simple
mathematical model was constructed for
boys < 15 years.
The relationship between the observed
rates of orchidopexies and the true prevalence
of cryptorchidism could be represented by the
equation y = x + kix, where y represents the
observed rate of orchidopexies and x repre-
sents the rate of orchidopexies performed for
cryptorchidism. The rate of orchidopexies
performed because of misdiagnosed cryp-
torchidism (e.g., for retractile testes) can be
expressed as kix, where ki is the multiplying
factor for year i. We have assumed that the
number of operations performed for reasons
other than true or misdiagnosed cryp-
torchidism, for example, for torsion or hydro-
cele, in this age group is very small and
constant and therefore of negligible impact.
The observed rate of orchidopexies in
0–14-year-olds in 1992–1993 was 23.5 per
10,000 males. If 50% of orchidopexies in that
year were performed because of misdiagnosed
retractile testes, a figure consistent with the
John Radcliffe cohort study findings for 
the late 1980s (John Radcliffe Hospital
Cryptorchidism Research Group 1986) and
the calculations of Chilvers et al. (1984), then
the value of k1992–1993 = 1 and the underlying
rate of cryptorchidism could be estimated as
11.75 per 10,000.
The observed rate of orchidopexies in
1998–1999 in 0–14–year-olds was 15.8 per
10,000. If we assume no change in the under-
lying rate of cryptorchidism between
1992–1993 and 1998–1999, this gives the
equation 15.8 = 11.75 + k1998–1999(11.75),
and therefore the value k1998–1999 = 0.34.
This means that for each orchidopexy per-
formed for true cryptorchidism, a further
0.34 were performed for misdiagnosed cryp-
torchidism; therefore, the proportion of
orchidopexies performed for misdiagnosed
retractile testes was 0.34/(1 + 0.34) or 25%,
half that in 1992–1993. This would represent
a fairly dramatic improvement in diagnostic
ability affecting the whole country in the rela-
tively short time period of 6 years.
If the underlying rate of cryptorchidism
had actually increased over this time period,
the corresponding improvement in diagnostic
ability would have had to have been even
greater than this to result in the observed
decline in orchidopexy rates. The data also
allow for an interpretation of a decrease in the
underlying frequency of cryptorchidism,
accompanied by a smaller or no improvement
in diagnostic ability.
Conclusion. Although the relationship
between orchidopexy and cryptorchidism is
complex, we believe that our findings may
reﬂect either an underlying decrease in the fre-
quency of undescended testis or a marked
improvement in the diagnosis of cryp-
torchidism—resulting in fewer orchidopexies
performed for retractile testis—in Great
Britain during the 1990s, or both. An increase
in the prevalence of cryptorchidism cannot be
ruled out, but for this to be a possibility, given
the observed trends in orchidopexy, a dra-
matic improvement in diagnostic ability
would have had to have occurred simultane-
ously over a short period, which we regard as
an unlikely scenario. Our findings warrant
further investigation with individual-level
studies, because this is a surprising finding
given reported trends of large increases in
cryptorchidism for previous decades and the
postulate of a recent worsening of male repro-
ductive health as suggested by the endocrine
disruptor hypothesis.
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